Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 441-450 of 11529

Edit search filters
  1. Five Or Ten Year Colonoscopy For 1-2 Non-Advanced Adenomatous Polyps (FORTE)

    Rochester, MN

  2. Marani Health M Care Study

    Rochester, MN

  3. Quanta Home Run Trial

    Rochester, MN

  4. Protonix Treatment Of Maintenance Of Healing In Pediatric Participants Aged 1-11 Years And 12-17 Years

    Rochester, MN

  5. A Trial Of CP101 For The Prevention Of Recurrent CDI (PRISM4)

    Rochester, MN

  6. Acute And Chronic Repercussion Of Spinal Cord Stimulation After Spinal Cord Injury

    Rochester, MN

  7. Study Of Intralesional Cemiplimab In Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

    Scottsdale/Phoenix, AZ

  8. Paclitaxel-Coated Pulmonary Balloon For The Treatment Of Benign Central Airway Stenosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Treatment Of Antibody-Mediated Rejection (ABMR) With CarBel

    Scottsdale/Phoenix, AZ

  10. ADG126 In Combination With Pembrolizumab In Patients With Advanced/Metastatic Solid Tumors

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer